Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,612.21
(
0.16%
)
US TECH 100
29,757.20
(
0.16%
)
Dow Jones
51,113.45
(
0.07%
)
Brent Oil
94.11
(
-1.94%
)
Bitcoin
67,617.70
(
-5.27%
)
News Focus
News Focus
Post# of 828730
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

flipper44

Send PM Follow Ignore
Followers 309
Posts 37503
Boards Moderated 1
Alias Born 11/14/2013

flipper44

Member Level

Re: FeMike post# 731624

Wednesday, 11/13/2024 8:32:25 AM

Wednesday, November 13, 2024 8:32:25 AM

Post# of 828730
It’s fascinating this is the least discussed major section last night and this morning.

Anyway, I’ll repeat that my bet is on Merck and Oncovir, but my feelings wouldn’t be hurt if it was someone other than Merck.

What’s remarkable is that the completed contract is limited to one synergistic company and one booster manufacturing company.

That sounds like, to me, the multiple companies NWBO was negotiating with were set aside for a company more interested in exclusivity.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News